FOR IMMEDIATE RELEASE:

AMERICAN BIO MEDICA TO RELEASE FIRST QUARTER EARNINGS AND HOST CONFERENCE CALL

KINDERHOOK, N.Y. -- April 29, 2024 -- American Bio Medica Corporation (NASDAQ: ABMC), will release its first quarter earnings on Wednesday, April 30, 2024 after trading ends on the Nasdaq Stock Market. The Company will also host a conference call on Thursday, May 1, 2003, at 8:30 a.m. EST to discuss the first quarter results and business outlook.

Investors and interested parties are invited to participate. The call will be broadcast live over the internet at www.abmc.com/investor/. The webcast will be listen-only mode. Listeners are requested to be online at least fifteen minutes early to register, as well as to download and install any complimentary audio software that might be required. To ask questions, you are invited to participate by phone. Within the United States, dial 1-800-360-9865 and internationally dial 973-694-6836. The call will be available for replay on the Company's website at www.abmc.com/investor/ for 30 days.

About American Bio Medica Corporation

American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate, onsite drugs-of-abuse diagnostic kits and support services worldwide. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen®, Rapid One® Rapid Tec® and Rapid Tec Cup™ test for the presence or absence of drugs of abuse in urine, while its OralStat6® tests for the presence or absence of drugs of abuse in saliva. ABMC was recently named among the 2002 Deloitte & Touche Technology Fast 500, a listing of the fastest-growing technology companies in North America.


Contact:
     American Bio Medica Corporation
     Gerald A. Moore, 800/227-1243
     gmoore@abmc.com